RAISE_2B | R Documentation |
Kaplan-Meier digitized data from RAISE, figure 2B (PMID 25877855). A reported sample size of 1,072 for a primary endpoint of OS in colorectal cancer.
RAISE_2B
A data frame of 1,072 observations and 3 variables:
time | event time (in months) | |
event | PFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (placebo_folfiri, ramucirumab_folfiri) | |
Tabernero J, Yoshino T, Cohn AL, et al. Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. Lancet Oncol 2015; 16: 499–508.
summary(RAISE_2B)
kmplot(RAISE_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.